Yasushi Fukushima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.
Journal: Diabetes, obesity & metabolism
Published: February 12, 2026
Esaxerenone versus angiotensin II receptor blockers as second-line therapy in older Japanese patients with uncontrolled hypertension on calcium channel blockers: the randomized, open-label ESCORT-HT study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: February 06, 2026
Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.
Journal: Advances in therapy
Published: November 18, 2025
Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial.
Journal: Diabetes, obesity & metabolism
Published: August 19, 2025
Inhaled anti-thymic stromal lymphopoietin antibody fragment, ecleralimab, in severe asthma: A placebo-controlled, multicenter, double-blind, randomized, phase 2b clinical trial.
Journal: American journal of respiratory and critical care medicine
Published: June 20, 2025
Inhaled anti-thymic stromal lymphopoietin antibody fragment, ecleralimab, in severe asthma: A placebo-controlled, multicenter, double-blind, randomized, phase 2b clinical trial.
Journal: American journal of respiratory and critical care medicine
Published: June 20, 2025
Effectiveness of indacaterol/glycopyrronium/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy.
Journal: The journal of allergy and clinical immunology. Global
Published: December 26, 2024
Efficacy and safety of danuglipron (PF-06882961) in adults with obesity: A randomized, placebo-controlled, dose-ranging phase 2b study.
Journal: Diabetes, obesity & metabolism
Published: December 22, 2024
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 20, 2024
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.
Journal: The New England journal of medicine
Published: October 16, 2024
Burden of respiratory syncytial virus infections in older adults with acute respiratory infection in Japan: An epidemiological study among outpatients.
Journal: Respiratory investigation
Published: April 12, 2024
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
Journal: The New England journal of medicine
Published: April 05, 2023
Last Updated: 09/26/2026